Ligand Pharmaceuticals - 27 Year Stock Price History | LGND

Historical daily share price chart and data for Ligand Pharmaceuticals since 1992 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Ligand Pharmaceuticals as of February 21, 2019 is 117.18.
Ligand Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 122.3366 137.0000 142.4700 110.0500 117.1800 -13.65%
2018 187.6862 138.6300 274.4900 128.3600 135.7000 -0.90%
2017 120.9272 102.5000 147.0400 100.3800 136.9300 34.76%
2016 108.9749 102.4700 138.5300 85.7900 101.6100 -6.28%
2015 86.5684 53.7300 111.8500 51.5400 108.4200 103.76%
2014 59.1922 51.5200 79.5800 42.3600 53.2100 1.16%
2013 37.1462 20.7200 57.9500 19.1602 52.6000 153.62%
2012 15.9545 11.9100 21.5300 11.4900 20.7400 74.73%
2011 11.4795 8.9900 15.9500 8.6500 11.8700 33.07%
2010 9.8156 13.0200 13.0200 8.2700 8.9200 -31.49%
2009 15.3079 16.2000 18.9000 9.9600 13.0200 -20.80%
2008 19.3233 29.1600 29.1600 7.6200 16.4400 -43.27%
2007 40.0625 49.1926 58.5712 23.4000 28.9800 -41.30%
2006 49.4716 51.8529 62.2356 35.8461 49.3730 -1.79%
2005 37.0503 50.5002 52.5292 21.4175 50.2748 -4.21%
2004 64.4892 67.3186 108.3049 35.4403 52.4841 -20.76%
2003 48.4792 24.6639 72.6842 16.8184 66.2364 173.56%
2002 51.9901 76.8775 90.1338 22.1389 24.2130 -70.00%
2001 54.3123 61.9980 85.6700 35.3952 80.7101 27.86%
2000 63.8520 62.5842 114.7076 44.3680 63.1252 8.70%
1999 44.1596 50.4551 62.8547 29.5787 58.0752 10.75%
1998 53.9537 57.4891 72.7293 25.9264 52.4390 -9.71%
1997 60.3340 69.2574 82.5588 41.1667 58.0752 -13.44%
1996 59.4135 46.8029 85.6700 46.2167 67.0931 38.42%
1995 35.4426 36.0716 49.5984 24.7992 48.4712 30.30%
1994 53.3798 54.1074 64.2525 28.1809 37.1988 -29.79%
1993 46.0966 55.2346 55.2346 39.4533 52.9801 11.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.527B $0.251B
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Biogen (BIIB) United States $65.929B 12.77
Celgene (CELG) United States $63.373B 11.74
Vertex Pharmaceuticals (VRTX) United States $48.023B 64.33
Regeneron Pharmaceuticals (REGN) United States $46.170B 21.45
Illumina (ILMN) United States $44.429B 52.84
Alexion Pharmaceuticals (ALXN) United States $29.015B 17.98
Incyte (INCY) United States $17.925B 167.48
BioMarin Pharmaceutical (BMRN) United States $16.143B 0.00
Seattle Genetics (SGEN) United States $11.201B 0.00
Exact Sciences (EXAS) United States $10.278B 0.00
Sarepta Therapeutics (SRPT) United States $9.393B 0.00
QIAGEN (QGEN) Netherlands $8.890B 29.07
Alnylam Pharmaceuticals (ALNY) United States $8.262B 0.00
BeiGene (BGNE) Cayman Islands $8.259B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bio-Techne Corp (TECH) United States $7.316B 49.29
Bluebird Bio (BLUE) United States $7.298B 0.00
Moderna (MRNA) United States $6.553B 0.00
Exelixis (EXEL) United States $6.350B 14.85
Amarin (AMRN) Ireland $5.554B 0.00
Alkermes (ALKS) Ireland $5.204B 0.00
Galapagos (GLPG) Belgium $5.177B 0.00
Array BioPharma (ARRY) United States $5.056B 0.00
Guardant Health (GH) United States $4.324B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.034B 0.00
Allogene Therapeutics (ALLO) United States $3.728B 0.00
Horizon Pharma Public (HZNP) Ireland $3.611B 14.85
Blueprint Medicines (BPMC) United States $3.388B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.346B 0.00
Emergent Biosolutions (EBS) United States $3.319B 27.96
Ultragenyx Pharmaceutical (RARE) United States $3.062B 0.00
Genomic Health (GHDX) United States $3.022B 78.93
Ascendis Pharma (ASND) Denmark $2.941B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.937B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.854B 0.00
Immunomedics (IMMU) United States $2.735B 0.00
China Biologic Products (CBPO) China $2.677B 19.06
Global Blood Therapeutics (GBT) United States $2.640B 0.00
Reata Pharmaceuticals (RETA) United States $2.596B 0.00
Repligen (RGEN) United States $2.588B 80.82
Mirati Therapeutics (MRTX) United States $2.585B 0.00
Arena Pharmaceuticals (ARNA) United States $2.464B 0.00
Halozyme Therapeutics (HALO) United States $2.439B 54.42
Myriad Genetics (MYGN) United States $2.343B 23.87
Akcea Therapeutics (AKCA) United States $2.343B 0.00
Amicus Therapeutics (FOLD) United States $2.099B 0.00
Insmed (INSM) United States $2.006B 0.00
Denali Therapeutics (DNLI) United States $1.999B 0.00
Acceleron Pharma (XLRN) United States $1.940B 0.00
Spark Therapeutics (ONCE) United States $1.921B 0.00
Atara Biotherapeutics (ATRA) United States $1.798B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.782B 0.00
Medicines (MDCO) United States $1.765B 0.00
MyoKardia (MYOK) United States $1.757B 0.00
AnaptysBio (ANAB) United States $1.740B 0.00
NeoGenomics (NEO) United States $1.724B 141.92
CRISPR Therapeutics AG (CRSP) Switzerland $1.660B 0.00
REGENXBIO (RGNX) United States $1.657B 22.23
Zai Lab Unsponsored ADR (ZLAB) China $1.637B 0.00
Allakos (ALLK) United States $1.530B 0.00
Innoviva (INVA) United States $1.482B 4.09
Myovant Sciences (MYOV) United Kingdom $1.479B 0.00
UniQure (QURE) Netherlands $1.467B 0.00
ALECTOR INC (ALEC) United States $1.430B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.388B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
Aimmune Therapeutics (AIMT) United States $1.363B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.342B 0.00
Cambrex (CBM) United States $1.286B 13.87
Clovis Oncology (CLVS) United States $1.278B 0.00
GOSSAMER BIO (GOSS) United States $1.273B 0.00
Lion Biotechnologies (IOVA) United States $1.218B 0.00
Codexis (CDXS) United States $1.178B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.115B 0.00
Audentes Therapeutics (BOLD) United States $1.110B 0.00
WAVE Life Sciences (WVE) Singapore $1.093B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.076B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.072B 43.32
Rubius Therapeutics (RUBY) United States $1.067B 0.00
Puma Biotechnology (PBYI) United States $1.020B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.011B 0.00
Coherus BioSciences (CHRS) United States $0.986B 0.00
Editas Medicine (EDIT) United States $0.983B 0.00
Epizyme (EPZM) United States $0.967B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.959B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.958B 0.00
Fate Therapeutics (FATE) United States $0.926B 0.00
Retrophin (RTRX) United States $0.864B 0.00
Sangamo Therapeutics (SGMO) United States $0.864B 0.00
Athenex (ATNX) United States $0.854B 0.00
Vericel (VCEL) United States $0.840B 0.00
CytomX Therapeutics (CTMX) United States $0.791B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.782B 0.00
Apellis Pharmaceuticals (APLS) United States $0.780B 0.00
InflaRx (IFRX) Germany $0.767B 0.00
Novavax (NVAX) United States $0.766B 0.00
G1 THERAPEUTICS (GTHX) United States $0.752B 0.00
Heska (HSKA) United States $0.751B 61.47
Intra-Cellular Therapies (ITCI) United States $0.733B 0.00
Principia Biopharma (PRNB) United States $0.724B 0.00
ANI Pharmaceuticals (ANIP) United States $0.721B 13.80
Cellectis (CLLS) France $0.715B 0.00
Arvinas (ARVN) United States $0.711B 0.00
Dynavax Technologies (DVAX) United States $0.689B 0.00
Revance Therapeutics (RVNC) United States $0.665B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.654B 0.00
Cara Therapeutics (CARA) United States $0.650B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.641B 0.00
Synthorx (THOR) United States $0.637B 0.00
Twist Bioscience (TWST) United States $0.630B 0.00
Viking Therapeutics (VKTX) United States $0.627B 0.00
Acorda Therapeutics (ACOR) United States $0.623B 8.09
Intellia Therapeutics (NTLA) United States $0.604B 0.00
RA PHARMCTL INC (RARX) United States $0.601B 0.00
UROGEN PHARMA (URGN) Israel $0.573B 0.00
Kura Oncology (KURA) United States $0.572B 0.00
Anika Therapeutics (ANIK) United States $0.569B 23.56
Eidos Therapeutics (EIDX) United States $0.567B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
Osiris Therapeutics (OSIR) United States $0.554B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.550B 0.00
Prothena (PRTA) Ireland $0.535B 0.00
Arcus Biosciences (RCUS) United States $0.516B 0.00
PDL BioPharma (PDLI) United States $0.511B 8.33
DBV Technologies (DBVT) France $0.493B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.492B 0.00
Zymeworks (ZYME) Canada $0.482B 0.00
UNITY Biotechnology (UBX) $0.477B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.476B 0.00
Senesco Technologies (ELOX) United States $0.458B 0.00
Scholar Rock Holding (SRRK) United States $0.455B 0.00
Zealand Pharma (ZEAL) Denmark $0.453B 5.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.445B 0.00
BeyondSpring (BYSI) United States $0.444B 0.00
ObsEva SA (OBSV) Switzerland $0.439B 0.00
Replimune (REPL) United States $0.437B 0.00
Five Prime Therapeutics (FPRX) United States $0.421B 0.00
Kezar Life Sciences (KZR) United States $0.403B 0.00
Cytokineticsorporated (CYTK) United States $0.402B 0.00
Mesoblast (MESO) Australia $0.401B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.398B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.387B 0.00
OSMOTICA PHARM (OSMT) United States $0.375B 0.00
Stemline Therapeutics (STML) United States $0.372B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.371B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
Kindred Biosciences (KIN) United States $0.364B 0.00
MediciNova (MNOV) United States $0.362B 0.00
AVROBIO (AVRO) United States $0.360B 0.00
Agenus (AGEN) United States $0.359B 0.00
Inovio Pharmaceuticals (INO) United States $0.358B 0.00
MeiraGTx Holdings (MGTX) United States $0.354B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.340B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
BioDelivery Sciences (BDSI) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.327B 0.00
Urovant Sciences (UROV) United States $0.318B 0.00
Evelo Biosciences (EVLO) United States $0.315B 0.00
Abeona Therapeutics (ABEO) United States $0.314B 0.00
Albireo Pharma (ALBO) United States $0.310B 0.00
Solid Biosciences (SLDB) United States $0.309B 0.00
Cellular Biomedicine (CBMG) United States $0.308B 0.00
Aduro Biotech (ADRO) United States $0.307B 0.00
XBiotech (XBIT) United States $0.306B 0.00
Magenta Therapeutics (MGTA) United States $0.305B 0.00
Intec Pharma (NTEC) Israel $0.293B 0.00
Enochian BioSciences (ENOB) United States $0.291B 0.00
Constellation Pharmaceuticals (CNST) United States $0.288B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.282B 0.00
Kala Pharmaceuticals (KALA) United States $0.280B 0.00
AC Immune SA (ACIU) Switzerland $0.277B 0.00
Geron (GERN) United States $0.276B 0.00
Kadmon Holdings (KDMN) United States $0.273B 0.00
Sorrento Therapeutics (SRNE) United States $0.271B 0.00
Axsome Therapeutics (AXSM) United States $0.262B 0.00
Liquidia Technologies (LQDA) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.258B 0.00
Merus (MRUS) Netherlands $0.254B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.252B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.251B 0.00
Synlogic (SYBX) United States $0.242B 0.00
Seres Therapeutics (MCRB) United States $0.241B 0.00
Celcuity (CELC) United States $0.240B 0.00
Kamada (KMDA) Israel $0.236B 10.64
MannKind (MNKD) United States $0.235B 0.00
Verastem (VSTM) United States $0.231B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.229B 0.00
ResTORbio (TORC) United States $0.225B 0.00
Adverum Biotechnologies (ADVM) United States $0.225B 0.00
Strongbridge Biopharma (SBBP) United States $0.218B 0.00
ChromaDex (CDXC) United States $0.215B 0.00
Cerecor (CERC) United States $0.211B 0.00
Athersys (ATHX) United States $0.210B 0.00
Celyad SA (CYAD) Belgium $0.209B 0.00
TOCAGEN INC (TOCA) United States $0.207B 0.00
Syros Pharmaceuticals (SYRS) United States $0.205B 0.00
Arbutus Biopharma (ABUS) Canada $0.202B 0.00
LogicBio Therapeutics (LOGC) United States $0.201B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.199B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.196B 0.00
CorMedix Inc (CRMD) United States $0.196B 0.00
Spero Therapeutics (SPRO) United States $0.193B 0.00
Aptinyx (APTX) United States $0.187B 0.00
ADMA Biologics Inc (ADMA) United States $0.185B 0.00
Axovant Sciences (AXGT) United Kingdom $0.184B 0.00
Compugen (CGEN) Israel $0.181B 0.00
Protagonist Therapeutics (PTGX) United States $0.173B 0.00
Menlo Therapeutics (MNLO) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.163B 80.19
Mersana Therapeutics (MRSN) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.162B 0.00
VBI Vaccines (VBIV) United States $0.160B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.152B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.149B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
Proteostasis Therapeutics (PTI) United States $0.148B 0.00
BioTime (BTX) United States $0.146B 0.00
OvaScience (MLND) United States $0.142B 0.00
Allena Pharmaceuticals (ALNA) United States $0.133B 0.00
BioXcel Therapeutics (BTAI) United States $0.129B 0.00
Eton Pharmaceuticals (ETON) United States $0.129B 0.00
Cohbar (CWBR) United States $0.129B 0.00
Cue Biopharma (CUE) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.127B 0.00
Pfenex (PFNX) United States $0.124B 0.00
Unum Therapeutics (UMRX) United States $0.124B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.123B 0.00
Fortress Biotech (FBIO) United States $0.121B 0.00
XOMA (XOMA) United States $0.119B 0.00
Pluristem Therapeutics (PSTI) Israel $0.119B 0.00
Trevena (TRVN) United States $0.117B 0.00
Checkpoint Therapeutics (CKPT) United States $0.114B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Mustang Bio (MBIO) United States $0.112B 0.00
Anavex Life Sciences (AVXL) United States $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.107B 0.00
Equillium (EQ) United States $0.105B 0.00
VolitionRX (VNRX) Singapore $0.103B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.102B 0.00
Chiasma (CHMA) United States $0.097B 0.00
VTv Therapeutics (VTVT) United States $0.094B 0.00
NantKwest (NK) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Cel-Sci (CVM) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.081B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.079B 88.33
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.079B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.078B 0.00
Alimera Sciences (ALIM) United States $0.077B 0.00
INMUNE BIO INC (INMB) United States $0.077B 0.00
Provention Bio (PRVB) United States $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.076B 0.00
PHASEBIO PHARMA (PHAS) United States $0.073B 0.00
Aptose Biosciences (APTO) Canada $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.067B 0.00
Protalix BioTherapeutics (PLX) Israel $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.067B 12.66
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Celldex Therapeutics (CLDX) United States $0.065B 0.00
SESEN BIO, INC (SESN) United States $0.063B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
Evogene (EVGN) Israel $0.058B 0.00
Eyenovia (EYEN) United States $0.057B 0.00
ARAVIVE, INC (ARAV) United States $0.057B 4.98
Proteon Therapeutics (PRTO) United States $0.056B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.056B 0.00
VIVUS (VVUS) United States $0.056B 0.00
Clearside Biomedical (CLSD) United States $0.056B 0.00
Ophthotech (OPHT) United States $0.055B 0.00
Vaccinex (VCNX) United States $0.055B 0.00
Alcobra (ARCT) United States $0.053B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.052B 0.00
Asterias Biotherapeutics (AST) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Entera Bio (ENTX) Israel $0.051B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
OVID THERAPEUTC (OVID) United States $0.046B 0.00
Selecta Biosciences (SELB) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
VistaGen Therapeutics (VTGN) United States $0.042B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
Celsion (CLSN) United States $0.040B 0.00
OncoSec Medical (ONCS) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.038B 0.00
Curis (CRIS) United States $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Arsanis (ASNS) United States $0.037B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
AZURRX BIOPHARM (AZRX) United States $0.034B 0.00
Leap Therapeutics (LPTX) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.033B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.031B 5.08
Galena Biopharma (SLS) United States $0.031B 0.00
TRACON Pharmaceuticals (TCON) United States $0.029B 0.00
Motif Bio Plc (MTFB) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Oragenics (OGEN) United States $0.026B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Advaxis (ADXS) United States $0.025B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
Adial Pharmaceuticals (ADIL) United States $0.024B 0.00
Vical (VICL) United States $0.022B 0.00
BioPharmX (BPMX) United States $0.022B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
GTx (GTXI) United States $0.021B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
IBio (IBIO) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.63
ATyr Pharma (LIFE) United States $0.015B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Soligenix (SNGX) United States $0.015B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
RestorGenex (DFFN) United States $0.009B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Histogenics (HSGX) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00